PCMA Statement on New Avalere Study Examining Generic Drugs in Medicare
May 22, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement today on a new Avalere study, Generic...
PCMA Statement on the Administration’s Blueprint to Lower Drug Prices
May 11, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today on the Administration’s new Blueprint on drug...
PCMA: American Diabetes Association White Paper Confirms Drugmakers Set and Raise Insulin Prices
May 08, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement regarding a white paper released today by the American...
PCMA EVENTS
PCMA hosts three annual events: the sPCMA Business Forum, the PBM Policy Forum, and the PCMA Annual Meeting
PCMA’s conference brand is known for bringing together thought leaders and pharmacy benefit decision makers from PBMs, specialty pharmacies, and pharma and biotech manufacturers.
Learn MoreABOUT OUR INDUSTRY
PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others. PBMs are projected to save employers, unions, government programs, and consumers $654 billion— up to 30 percent—on drug benefit costs over the next decade.